Synergy Investment Management’s Biogen BIIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$11.2K Buy
52
+1
+2% +$191 ﹤0.01% 613
2026
Q1
$9.35K Buy
+51
New +$9.4K ﹤0.01% 503
2025
Q2
– Sell
-50
Closed -$6.84K – 121
2025
Q1
$6.84K Hold
50
– – ﹤0.01% 416
2024
Q4
$7.65K Buy
+50
New +$8.43K ﹤0.01% 415

Other funds holding BIIB

Synergy Investment Management's BIIB Position: Q2 2026 in Review

Synergy Investment Management increased its Biogen (BIIB) stake by 2% in Q2 2026, buying an estimated $191 and bringing the position to 52 shares worth $11.2K. The position accounts for ﹤0.01% of the portfolio, ranked #613.

Synergy Investment Management first reported a position in BIIB in Q4 2024 and has held it in 4 quarters since. 1,046 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.

  • Synergy Investment Management held 52 shares of Biogen worth $11.2K as of Q2 2026.
  • Synergy Investment Management bought 1 Biogen share in Q2 2026, an estimated $191.
  • Biogen made up ﹤0.01% of Synergy Investment Management's portfolio in Q2 2026, its #613 holding.
  • Synergy Investment Management first reported a position in Biogen in Q4 2024 and has held it in 4 quarters since.
  • 1,046 funds tracked by Wall St. Rank held Biogen as of Q2 2026.

Based on Synergy Investment Management's 13F filing for Q2 2026, filed 14 Aug 2026.